• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

瑞士不同专科患者骨质疏松症的风险因素、表现及认知:一项全国性调查结果

Risk Factors, Manifestation, and Awareness of Osteoporosis among Patients of Various Specialists in Switzerland: Results of a National Survey.

作者信息

Jehle-Kunz Sigrid, Häuselmann Hans-Jörg, Keschawarzi Mitra, Lamy Olivier, Luzuy Franck, Marcoli Natalie, Meier Christian, Uebelhart Brigitte, Wiedersheim Peter

机构信息

Center for Osteoporosis, St. Anna Clinic, 6003 Lucerne, Switzerland.

Center for Rheumatology and Bone Diseases, 8038 Zurich, Switzerland.

出版信息

Healthcare (Basel). 2022 Feb 3;10(2):295. doi: 10.3390/healthcare10020295.

DOI:10.3390/healthcare10020295
PMID:35206909
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8871550/
Abstract

Osteoporosis is the most common chronic metabolic bone disease, known to be underdiagnosed and undertreated in parts of the Swiss population. Due to expected rise in new fragility fractures, adequate awareness of associated risk factors and diagnostic and therapeutic options will be essential for the management of osteoporosis. We therefore explored these aspects in a nationwide survey of Swiss specialists and their patients. A total of 262 physician questionnaires and 9065 patient questionnaires were analyzed, mainly from general practitioners (64.9%), followed by rheumatologists (16.8%), gynecologists (12.2%), and endocrinologists (6.1%). Around 20% of patients were under medication and/or had a medical condition increasing the risk of osteoporosis. Further risk factors, such as low consumption of calcium-rich foods, smoking, elevated alcohol intake, and insufficient physical activity, were present across regions and medical fields. 53.9% of patients did not take calcium/vitamin D supplements; 3.5% reported having fragility fractures, and 7.3% received treatment for osteoporosis. Only 38.5% of surveyed patients knew of the chronic nature of osteoporosis, indicating rather low awareness in this population. Despite generally perceived relevance of osteoporosis for daily practice, aspects of its prevention and management varied across regions and medical fields. Raising awareness among patients and physicians will be vital for addressing osteoporosis on a national scale.

摘要

骨质疏松症是最常见的慢性代谢性骨病,在瑞士部分人群中存在诊断不足和治疗不足的情况。由于预计脆性骨折的新发病例将会增加,充分认识相关风险因素以及诊断和治疗选择对于骨质疏松症的管理至关重要。因此,我们在一项针对瑞士专家及其患者的全国性调查中探讨了这些方面。共分析了262份医生问卷和9065份患者问卷,主要来自全科医生(64.9%),其次是风湿病学家(16.8%)、妇科医生(12.2%)和内分泌学家(6.1%)。约20%的患者正在接受药物治疗和/或患有增加骨质疏松症风险的疾病。其他风险因素,如富含钙的食物摄入不足、吸烟、酒精摄入量增加和体育活动不足,在各个地区和医学领域都存在。53.9%的患者未服用钙/维生素D补充剂;3.5%的患者报告有脆性骨折,7.3%的患者接受了骨质疏松症治疗。只有38.5%的受访患者知道骨质疏松症的慢性性质,表明该人群的知晓率相当低。尽管普遍认为骨质疏松症与日常医疗实践相关,但其预防和管理在不同地区和医学领域存在差异。提高患者和医生的认识对于在全国范围内应对骨质疏松症至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6d8/8871550/f26d98096eb8/healthcare-10-00295-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6d8/8871550/0323f733a242/healthcare-10-00295-g0A1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6d8/8871550/190a0fc7894d/healthcare-10-00295-g0A2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6d8/8871550/f18330b27f37/healthcare-10-00295-g0A3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6d8/8871550/f28b0964ee78/healthcare-10-00295-g0A4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6d8/8871550/506ab80ca0b8/healthcare-10-00295-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6d8/8871550/b6198e92ae2d/healthcare-10-00295-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6d8/8871550/ce58f06c66ce/healthcare-10-00295-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6d8/8871550/aa3855632d80/healthcare-10-00295-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6d8/8871550/91a6ed8c25ca/healthcare-10-00295-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6d8/8871550/54dc3917abfe/healthcare-10-00295-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6d8/8871550/afcfa5658ab9/healthcare-10-00295-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6d8/8871550/88c955ceb97a/healthcare-10-00295-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6d8/8871550/f26d98096eb8/healthcare-10-00295-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6d8/8871550/0323f733a242/healthcare-10-00295-g0A1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6d8/8871550/190a0fc7894d/healthcare-10-00295-g0A2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6d8/8871550/f18330b27f37/healthcare-10-00295-g0A3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6d8/8871550/f28b0964ee78/healthcare-10-00295-g0A4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6d8/8871550/506ab80ca0b8/healthcare-10-00295-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6d8/8871550/b6198e92ae2d/healthcare-10-00295-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6d8/8871550/ce58f06c66ce/healthcare-10-00295-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6d8/8871550/aa3855632d80/healthcare-10-00295-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6d8/8871550/91a6ed8c25ca/healthcare-10-00295-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6d8/8871550/54dc3917abfe/healthcare-10-00295-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6d8/8871550/afcfa5658ab9/healthcare-10-00295-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6d8/8871550/88c955ceb97a/healthcare-10-00295-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6d8/8871550/f26d98096eb8/healthcare-10-00295-g009.jpg

相似文献

1
Risk Factors, Manifestation, and Awareness of Osteoporosis among Patients of Various Specialists in Switzerland: Results of a National Survey.瑞士不同专科患者骨质疏松症的风险因素、表现及认知:一项全国性调查结果
Healthcare (Basel). 2022 Feb 3;10(2):295. doi: 10.3390/healthcare10020295.
2
Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.安大略省双能X线吸收法骨密度测定的应用:基于证据的分析。
Ont Health Technol Assess Ser. 2006;6(20):1-180. Epub 2006 Nov 1.
3
Physician and patient perceptions on the use of vitamin D and calcium in osteoporosis treatment: a European and Latin American perspective.医生与患者对维生素D和钙在骨质疏松症治疗中应用的看法:欧洲和拉丁美洲视角
Curr Med Res Opin. 2007 Jun;23(6):1227-37. doi: 10.1185/030079907X187964. Epub 2007 Apr 30.
4
Survey of spine surgeons on attitudes regarding osteoporosis and osteomalacia screening and treatment for fractures, fusion surgery, and pseudoarthrosis.脊柱外科医生对骨质疏松症和骨软化症筛查及骨折治疗、融合手术和假关节的态度调查。
Spine J. 2009 Jul;9(7):537-44. doi: 10.1016/j.spinee.2009.02.005. Epub 2009 Mar 28.
5
Awareness of osteoporosis, risk and protective factors and own diagnostic status: a cross-sectional study.骨质疏松症意识、风险和保护因素以及自身诊断状况:一项横断面研究。
Arch Osteoporos. 2013;8:117. doi: 10.1007/s11657-012-0117-9. Epub 2013 Jan 8.
6
Diagnosis, prevention, and treatment of bone fragility in people living with HIV: a position statement from the Swiss Association against Osteoporosis.诊断、预防和治疗 HIV 感染者的骨脆弱症:瑞士抗骨质疏松协会立场声明。
Osteoporos Int. 2019 May;30(5):1125-1135. doi: 10.1007/s00198-018-4794-0. Epub 2019 Jan 2.
7
Calcium and vitamin D nutrition and bone disease of the elderly.老年人的钙和维生素D营养与骨病
Public Health Nutr. 2001 Apr;4(2B):547-59. doi: 10.1079/phn2001140.
8
The need for clinical guidance in the use of calcium and vitamin D in the management of osteoporosis: a consensus report.骨质疏松症管理中钙和维生素D使用的临床指南需求:一份共识报告。
Osteoporos Int. 2004 Jul;15(7):511-9. doi: 10.1007/s00198-004-1621-6.
9
Clinical risk factors for osteoporosis are common among elderly people in Nuuk, Greenland.骨质疏松症的临床风险因素在格陵兰努克的老年人中很常见。
Int J Circumpolar Health. 2013;72:19596. doi: 10.3402/ijch.v72i0.19596. Epub 2013 Jan 11.
10
Prevention and treatment of postmenopausal osteoporosis.绝经后骨质疏松症的预防与治疗。
Obstet Gynecol Clin North Am. 2008 Jun;35(2):301-15, ix. doi: 10.1016/j.ogc.2008.03.007.

引用本文的文献

1
A Systematic Review of Research Tools, Research Status and Improvement Measures for Osteoporosis Awareness in Chinese and International.中国与国际骨质疏松症认知度的研究工具、研究现状及改进措施的系统评价
Int J Gen Med. 2025 Feb 15;18:801-813. doi: 10.2147/IJGM.S508268. eCollection 2025.
2
Study on the mechanism of naringin in promoting bone differentiation: In and study.柚皮苷促进骨分化的机制研究:在……和……研究中。 (你提供的原文似乎不完整,翻译可能不太准确,你可补充完整后再让我翻译)
Heliyon. 2024 Jan 18;10(2):e24906. doi: 10.1016/j.heliyon.2024.e24906. eCollection 2024 Jan 30.

本文引用的文献

1
2020 recommendations for osteoporosis treatment according to fracture risk from the Swiss Association against Osteoporosis (SVGO).2020 年瑞士骨质疏松症防治协会(SVGO)基于骨折风险的骨质疏松治疗建议。
Swiss Med Wkly. 2020 Sep 29;150:w20352. doi: 10.4414/smw.2020.20352. eCollection 2020 Sep 21.
2
The osteoporosis treatment gap in patients at risk of fracture in European primary care: a multi-country cross-sectional observational study.骨质疏松症治疗差距:欧洲初级保健中骨折风险患者的多国家横断面观察性研究。
Osteoporos Int. 2021 Feb;32(2):251-259. doi: 10.1007/s00198-020-05557-z. Epub 2020 Aug 23.
3
Osteoporosis prevention: Where are the barriers to improvement in French general practitioners? A qualitative study.
骨质疏松症预防:法国全科医生改善的障碍在哪里?一项定性研究。
PLoS One. 2019 Jul 16;14(7):e0219681. doi: 10.1371/journal.pone.0219681. eCollection 2019.
4
Bone Mineral Density Among Men and Women Aged 35 to 50 Years.35至50岁男性和女性的骨密度
J Am Osteopath Assoc. 2019 Jun 1;119(6):357-363. doi: 10.7556/jaoa.2019.064.
5
Cost-benefit analysis of calcium and vitamin D supplements.钙剂和维生素 D 补充剂的成本效益分析。
Arch Osteoporos. 2019 Apr 30;14(1):50. doi: 10.1007/s11657-019-0589-y.
6
Prevalence and comorbidity of osteoporosis- a cross-sectional analysis on 10,660 adults aged 50 years and older in Germany.骨质疏松症的患病率及共病情况——对德国10660名50岁及以上成年人的横断面分析
BMC Musculoskelet Disord. 2018 May 14;19(1):144. doi: 10.1186/s12891-018-2060-4.
7
Appropriateness of bone density measurement in Switzerland: a cross-sectional study.瑞士骨密度测量的适宜性:一项横断面研究。
BMC Public Health. 2018 Apr 2;18(1):423. doi: 10.1186/s12889-018-5305-0.
8
Major Differences in Diet across Three Linguistic Regions of Switzerland: Results from the First National Nutrition Survey menuCH.瑞士三大语言区饮食的主要差异:瑞士首次全国营养调查菜单 CH 的结果。
Nutrients. 2017 Oct 25;9(11):1163. doi: 10.3390/nu9111163.
9
How General Practitioners and Their Patients Adhere to Osteoporosis Management: A Follow-Up Survey among Czech General Practitioners.全科医生及其患者如何坚持骨质疏松症管理:捷克全科医生的随访调查
Front Pharmacol. 2017 May 11;8:258. doi: 10.3389/fphar.2017.00258. eCollection 2017.
10
UK clinical guideline for the prevention and treatment of osteoporosis.英国临床指南:骨质疏松症的预防和治疗。
Arch Osteoporos. 2017 Dec;12(1):43. doi: 10.1007/s11657-017-0324-5. Epub 2017 Apr 19.